Dr. Harsh Vardhan Launches the ‘Sanjivani’ App

▴ medicircle-dr-harsh-vardhan-launches-the-sanjivani-app
Dr. Harsh Vardhan launches the ‘Sanjivani’ App and inter-disciplinary studies involving AYUSH interventions for COVID 19

Dr. Harsh Vardhan, Union Health & Family Welfare Minister launched the ‘Sanjivani’ App and two AYUSH based studies related to COVID-19 situation, here today, in the presence of Shri Shripad Yesso Naik, MoS (I/c), AYUSH who participated through Video Conferencing from Goa.

Highlighting the importance of harnessing technology for COVID-19 response, the Union Health Minister said “The ‘Sanjivani’ mobile app, which has been launched today, will help to generate data on acceptance and usage of AYUSH advocacies and measures among the population and its impact in prevention of COVID 19. It is developed by Ministry of AYUSH and MEITY and shall reach out to a target of 50 lakh people.”

Dr. Harsh Vardhan stated that COVID-19 mangement has provided a potent platform for alliance between MoHFW, MoAYUSH and technology organisations such as CSIR, ICMR, and UGC to not only develop AYUSH interventions and solutions, but also help in promoting AYUSH knowledge for the larger good of the global community. These organisations are joinging hands today and are being supported and guided by ICMR and DCGI in propagating the wholesomeness and holistic health benefits of the age-old traditional medicinal knolwedge of Ayurveda, he added.

In addition to the App, Dr Harsh Vardhan also launched two more scientific studies. One is the collaborative clinical research study on Ayurveda interventions as prophylaxis and as an add-on to standard care to COVID 19, which shall be a joint initiative of Ministry of AYUSH, Ministry of Health and Family Welfare (MoHFW) and the Ministry of Science & Technology through Council of Scientific & Industrial Research (CSIR) with technical support of ICMR. The Interdisciplinary Ayush R&D Task Force headed by Dr Bhushan Patvardhan, Vice Chairman, University Grant Commission (UGC), has formulated and designed clinical research protocols for prophylactic studies and add-on interventions in COVID-19 positive cases through thorough review and consultative process of experts of high repute from different organisations across the country for studying four different interventions viz. Ashwagandha, Yashtimadhu, Guduchi +Pippali and a poly herbal formulation (AYUSH-64). This includes the following two areas:

Ashwagandha for the Prophylaxis Against SARS-COV-2 in subjects with increased risk during the COVID 19 Pandemic: A comparison with Hydroxychloroquine in the health care providers, and
Effectiveness of Ayurveda Formulation as an adjunct to ‘Standard of Care’ for the Treatment of Mild to Moderate COVID-19: A Randomized, Open Label, Parallel Efficacy, Active Control, Multi-Centre Exploratory Drug Trial.

Dr Harsh Vardhan also launched the population based interventional studies on impact of AYUSH based prophylactic interventions for prevention of COVID-19 infection in high risk population. The core objectives comprise of assessment of preventive potential of AYUSH interventions for COVID 19 and to assess the improvement in quality of life in high risk population. The study will be carried out through four Research Councils under Ministry of AYUSH and National Institutes in 25 states across the country and several State Governments covering approximately 5 lakh population. The outcome of the study is expected to pave a new horizon in understanding the preventive potential of AYUSH interventions during pandemics like COVID 19 through scientific evidence.

Elaborating on the import of these studies, Dr Harsh Vardhan stated that these studies shall re-establish the importance of AYUSH pathies with the help of rigour of CSIR, ICMR and DCGI. “This is truly a momentous day. The technology alliance provides valuable opportunity for such knowledge based solutions to continue to benefit us even after the COVID-19 pandemic has passed, by possible integration of AYUSH in the mainstream scientific efforts”, he added. Let us also understand that the modern pathies of medicine and science are not in competition with those of AYUSH, but they complement and strengthen each other in intrinsic ways, Dr Harsh Vardhan stated. Under the leadership of our beloved Prime Minister, AYUSH advisories for enhancing immunity during COVID-19 pandemic have been acknowledged the world over, he said.

Shri Rajesh Bhushan, OSD/Secretary (HFW), Shri Vaidya Rajesh Kotecha, Secretary, AYUSH, Dr. Shekhar Mande, Director General, Council of Scientific & Industrial Research, Dr. V. G. Somani, Drugs Controller General of India, and other senior officers of MoHFW and AYUSH were also present at the launch event.

Tags : #Drharshvardhan #Sanjivanimobileapp #Ayush #Ashwagandha

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

India's coronavirus cases rise to 5.2 million with 96,424 new infections and 87,472 recoveriesSeptember 19, 2020
UV light can kill Covid with our harming human : American Journal of Infection controlSeptember 19, 2020
Israel imposes second coronavirus lockdown during high holidaysSeptember 19, 2020
British DnaNudge coronavirus test is accurate : UK MHRASeptember 19, 2020
Uttar Pradesh conducts 1,50,000 tests per day while NCL donates 50 ambulances September 19, 2020
Male pattern baldness or Alopecia : What you should know September 18, 2020
Huntington Study Group partners with Prilenia Therapeutics : Phase 3 Clinical Study of Pridopidine September 18, 2020
Alarming rates of transmission of virus in EuropeSeptember 18, 2020
China Biopharma plant leak infects thousands with bacterial diseaseSeptember 18, 2020
WHO urges safety for health workers bearing brunt of CoronavirusSeptember 18, 2020
Moderna to seek COVID vaccine's limited emergency useSeptember 18, 2020
Gujarat reports record 1379 new cases of COVID-19 in last 24 hoursSeptember 18, 2020
Global Coronavirus cases surpass 30 MillionSeptember 18, 2020
Karnataka reports 9366 new COVID-19 positive cases in last 24 hoursSeptember 18, 2020
Pulmonary Arterial Hypertension treatment : Moderna and Chiesi Group collaboratesSeptember 18, 2020
Sero survey begins in Chhattisgarh amid rising COVID-19 casesSeptember 18, 2020
WHO calls for protective equipments for frontline medical workersSeptember 18, 2020
Around 15 thousand Railway employees affected by Corona virusSeptember 18, 2020
Elicio Therapeutics collaborates with Moffitt Cancer CenterSeptember 18, 2020
NGO from Maharashtra filed a PIL on COVID-19 drugsSeptember 18, 2020